Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer

Purpose: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have been...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cancer
Main Authors: Domvri, Kalliopi, Zarogoulidis, Konstantinos, Zogas, Nikolaos, Zarogoulidis, Paul, Petanidis, Savvas, Porpodis, Konstantinos, Kioseoglou, Efrosini, Hohenforst-Schmidt, Wolfgang
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2017
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688917/
https://ncbi.nlm.nih.gov/pubmed/29151951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.21783
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki